Comparison Trial Between Elastic-compressive Stockings at 21 Versus 32 mmHg (CALESSE)

January 9, 2024 updated by: Daniela Mazzaccaro, IRCCS Policlinico S. Donato

ElaStic-compressive Stockings at 21 mmHg and 32 mmHg Following Thermal Ablation of the Great Saphenous Vein.

Endovascular thermal ablation is currently considered as the best procedure for treating varicose veins thanks to its mini-invasiveness and the lowest rate of incidence of complications. At the end of the endovascular ablation procedure, the European Society of Vascular Surgery (ESVS) guidelines recommend the use of the compression stockings to reduce postoperative pain and the incidence of edema and thrombotic complications.

Despite this, the duration, type and degree of compression to be used, particularly after radiofrequency ablation procedures, remain a matter of debate. Furthermore, although the benefits of postoperative elastic compression therapy are well known, there is various evidence demonstrating how patients often experience poor comfort in wearing stockings, especially those with a higher degree of compression, which causes poor compliance with therapy. In light of all this, each center recommends the use of elastic compression stockings in the postoperative period with a degree of compression that varies, however, according to internal protocols.

There is currently no work in the literature that compares the advantages and disadvantages of using elastic compression stockings with a K2 versus K1 compression degree after radiofrequency ablative surgery.

Study Overview

Status

Recruiting

Study Type

Interventional

Enrollment (Estimated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • adult patients (>18 years) suffering from varicose vein pathology of the lower limbs C2-3 class (varicose veins, edema) according to Clinic, Etiology, Anatomy, Pathophysiology (CEAP) classification, supported by incontinence of the great saphenous vein documented by Echo-Duplex study and candidates for thermal ablation by radiofrequency of the great vein saphenous vein with associated phlebectomy of the ipsilateral thigh and/or leg varices.

Exclusion Criteria:

  • Patients who are minors (< 18 years old) or adults who have not given their consent to participate in the study.
  • Presence of severe obliterating arterial disease of the lower limbs (ABI <0.5)
  • Obesity (BMI >30)
  • Varicose pathology of the lower limbs in C4-C6 class according to Clinic, Etiology, Anatomy, Pathophysiology (CEAP) classification (presence of:

lipodermatosclerosis/eczema and/or ulcers in progress and/or previous ulcers in the affected lower limb).

  • Pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: K1, 18-21 mmHg
Use of elastic stockings at 18-21 mmHg after endovenous thermal ablation
Use of Elastic-compressive stockings at 21 mmHg and 32 mmHg.
Experimental: K2, 23-32 mmHg
Use of elastic stockings at 23-32 mmHg after endovenous thermal ablation
Use of Elastic-compressive stockings at 21 mmHg and 32 mmHg.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain
Time Frame: 3 days after surgery
Evaluation of postoperative pain using the Visual Analogic pain Scale (1-10, being higher the pain the higher the value of the scale)
3 days after surgery
Postoperative Pain
Time Frame: 7 days after surgery
Evaluation of postoperative pain using the Visual Analogic pain Scale (1-10, being higher the pain the higher the value of the scale)
7 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower limb edema
Time Frame: 3 days from intervention
Evaluation of the circumference of the lower limb undergoing surgery in 3 points: 10 cm above the patella, at the level of the tibial tuberosity and 5 cm below the latter
3 days from intervention
Lower limb edema
Time Frame: 7 days from intervention
Evaluation of the circumference of the lower limb undergoing surgery in 3 points: 10 cm above the patella, at the level of the tibial tuberosity and 5 cm below the latter
7 days from intervention
Lower limb edema
Time Frame: 30 days from intervention
Evaluation of the circumference of the lower limb undergoing surgery in 3 points: 10 cm above the patella, at the level of the tibial tuberosity and 5 cm below the latter
30 days from intervention
Analgesic Drugs Use
Time Frame: 3 days from intervention
Evaluation of the possible use of analgesic drugs for postoperative pain.
3 days from intervention
Analgesic Drugs Use
Time Frame: 7 days from intervention
Evaluation of the possible use of analgesic drugs for postoperative pain.
7 days from intervention
Analgesic Drugs Use
Time Frame: 30 days from intervention
Evaluation of the possible use of analgesic drugs for postoperative pain.
30 days from intervention
Discomfort
Time Frame: 3 days from intervention
Evaluation of the discomfort caused to the patient by the use of stockings using the Aberdeen Varicose Veins Questionnaire .
3 days from intervention
Discomfort
Time Frame: 7 days from intervention
Evaluation of the discomfort caused to the patient by the use of stockings using the Aberdeen Varicose Veins Questionnaire .
7 days from intervention
Discomfort
Time Frame: 30 days from intervention
Evaluation of the discomfort caused to the patient by the use of stockings using the Aberdeen Varicose Veins Questionnaire .
30 days from intervention
Postoperative Complications
Time Frame: 3 days from intervention
Evaluation of the incidence of postoperative complications
3 days from intervention
Postoperative Complications
Time Frame: 7 days from intervention
Evaluation of the incidence of postoperative complications
7 days from intervention
Postoperative Complications
Time Frame: 30 days from intervention
Evaluation of the incidence of postoperative complications
30 days from intervention
Evaluation of Quality of Life
Time Frame: 3 days from intervention
Evaluation of the quality of life using a questionnaire
3 days from intervention
Evaluation of Quality of Life
Time Frame: 7 from intervention
Evaluation of the quality of life using a questionnaire
7 from intervention
Evaluation of Quality of Life
Time Frame: 30 days from intervention
Evaluation of the quality of life using a questionnaire.
30 days from intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2019

Primary Completion (Estimated)

November 30, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

February 17, 2023

First Submitted That Met QC Criteria

March 10, 2023

First Posted (Actual)

March 13, 2023

Study Record Updates

Last Update Posted (Actual)

January 10, 2024

Last Update Submitted That Met QC Criteria

January 9, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 41/int/2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The authors of the study are the owners of all data collected and will commit to the publication of the data themselves unconditionally and in full.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vascular Surgical Procedures

Clinical Trials on Elastic-compressive stockings

3
Subscribe